Menu
BIOMARKER IDENTIFICATION, THERAPY DISCOVERY AND TARGET VALIDATION
About Us
Our lab is housed within the Department of Biology in the College of Science and Math on the campus of California State University Northridge (CSUN).
By understanding what drives cancer progression/relapse and what prevents complete tissue regeneration, our group aims to develop novel tools and strategies to diagnose/treat cancer onset and progression.
By understanding what drives cancer progression/relapse and what prevents complete tissue regeneration, our group aims to develop novel tools and strategies to diagnose/treat cancer onset and progression.
Recent Publications
Tumor Microenvironment Heterogeneity: Challenges and Opportunities. Runa et al. Current Molecular Biology Reports 2017
ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer. Gharibi and Kim et al. Nature Scientific Reports 2017
ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer. Gharibi and Kim et al. Nature Scientific Reports 2017
